Glutamic acid decarboxylase antibodies (GADA) is the most important factor for prediction of insulin therapy within 3 years in young adult diabetic patients not classified as Type 1 diabetes on clinical grounds

Acid Decarboxylase ◽

Diabetic Patients ◽

Glutamic acid decarboxylase antibodies in idiopathic generalized epilepsy and type 1 diabetes

Annals of Neurology ◽

10.1002/ana.21011 ◽

2008 ◽

Vol 63 (1) ◽

pp. 127-128 ◽

Cited By ~ 16

Author(s):

Pasquale Striano ◽

Giuseppe Perruolo ◽

Luca Errichiello ◽

Pietro Formisano ◽

Francesco Beguinot ◽

...

Keyword(s):

Type 1 Diabetes ◽

Glutamic Acid ◽

Acid Decarboxylase ◽

Idiopathic Generalized Epilepsy ◽

Generalized Epilepsy

A Severe Case of Diabetic Ketoacidosis and New-Onset Type 1 Diabetes Mellitus Associated with Anti-Glutamic Acid Decarboxylase Antibodies Following Immunotherapy with Pembrolizumab

American Journal of Case Reports ◽

10.12659/ajcr.931702 ◽

2021 ◽

Vol 22 ◽

Author(s):

Sonya K. Kedzior ◽

Gabrielle Jacknin ◽

Andi Hudler ◽

Scott W. Mueller ◽

Tyree Heath Kiser

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Glutamic Acid ◽

Type 1 Diabetes Mellitus ◽

Severe Case ◽

Acid Decarboxylase ◽

New Onset

Class II HLA genotype in fulminant type 1 diabetes: A nationwide survey with reference to glutamic acid decarboxylase antibodies

Journal of Diabetes Investigation ◽

10.1111/j.2040-1124.2011.00139.x ◽

2011 ◽

Vol 3 (1) ◽

pp. 62-69 ◽

Cited By ~ 40

Author(s):

Chiharu Tsutsumi ◽

Akihisa Imagawa ◽

Hiroshi Ikegami ◽

Hideichi Makino ◽

Tetsuro Kobayashi ◽

...

Keyword(s):

Type 1 Diabetes ◽

Glutamic Acid ◽

Nationwide Survey ◽

Acid Decarboxylase ◽

Fulminant Type 1 Diabetes ◽

Hla Genotype ◽

Fulminant Type

Thyroid autoantibodies in Thai type 1 diabetic patients: clinical significance and their relationship with glutamic acid decarboxylase antibodies

Diabetes Research and Clinical Practice ◽

10.1016/s0168-8227(00)00146-7 ◽

2000 ◽

Vol 49 (2-3) ◽

pp. 107-111 ◽

Cited By ~ 9

Author(s):

Chatchalit Rattarasarn ◽

Manuel Aguilar Diosdado ◽

Jose Ortego ◽

Rattana Leelawattana ◽

Supamai Soonthornpun ◽

...

Keyword(s):

Glutamic Acid ◽

Clinical Significance ◽

Acid Decarboxylase ◽

Diabetic Patients ◽

Thyroid Autoantibodies ◽

Type 1 Diabetic Patients

Epilepsy and behavioral changes, type 1 diabetes mellitus and a high titer of glutamic acid decarboxylase antibodies

Pediatric Diabetes ◽

10.1111/pedi.12346 ◽

2015 ◽

Vol 17 (8) ◽

pp. 617-622 ◽

Cited By ~ 6

Author(s):

Esther Ganelin-Cohen ◽

Dalit Modan-Moses ◽

Rina Hemi ◽

Hannah Kanety ◽

Bruria Ben-zeev ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Glutamic Acid ◽

Type 1 Diabetes Mellitus ◽

High Titer ◽

Behavioral Changes ◽

Acid Decarboxylase ◽

A Patient with Type 1 Diabetes Mellitus and Cerebellar Ataxia Associated with High Titer of Circulating Anti-Glutamic Acid Decarboxylase Antibodies.

Endocrine Journal ◽

10.1507/endocrj.48.261 ◽

2001 ◽

Vol 48 (2) ◽

pp. 261-268 ◽

Cited By ~ 12

Author(s):

HIROAKI IWASAKI ◽

RYUJI SATO ◽

MASAYOSHI SHICHIRI ◽

YUKIO HIRATA

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Glutamic Acid ◽

Type 1 Diabetes Mellitus ◽

Cerebellar Ataxia ◽

High Titer ◽

Acid Decarboxylase ◽

Stiff person syndrome and cerebellar ataxia associated with glutamic acid decarboxylase antibodies and type 1 diabetes: What is the link between neurological diseases and autoimmunity to the beta cell?

Inmunología ◽

10.1016/s0213-9626(10)70003-2 ◽

2010 ◽

Vol 29 (4) ◽

pp. 119-124

Author(s):

Marta Vives-Pi ◽

Lidia Sabater

Keyword(s):

Type 1 Diabetes ◽

Beta Cell ◽

Glutamic Acid ◽

Cerebellar Ataxia ◽

Neurological Diseases ◽

Acid Decarboxylase ◽

Stiff Person Syndrome ◽

IgG4 subclass glutamic acid decarboxylase antibodies (GADA) are associated with a reduced risk of developing type 1 diabetes as well as increased C-peptide levels in GADA positive gestational diabetes

Clinical Immunology ◽

10.1016/j.clim.2015.11.001 ◽

2016 ◽

Vol 162 ◽

pp. 45-48

Author(s):

Jonatan Dereke ◽

Charlotta Nilsson ◽

Helena Strevens ◽

Mona Landin-Olsson ◽

Magnus Hillman

Keyword(s):

Type 1 Diabetes ◽

Gestational Diabetes ◽

Glutamic Acid ◽

Acid Decarboxylase ◽

C Peptide ◽

Reduced Risk

Faculty Opinions recommendation of Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717955696.793460711 ◽

2012 ◽

Author(s):

Mark Peakman

Keyword(s):

Type 1 Diabetes ◽

Glutamic Acid ◽

Acid Decarboxylase ◽

Double Blind Trial ◽

Double Blind ◽

Recent Onset ◽

Blind Trial ◽

Onset Type

Cross-reactive peptide epitopes of Enterovirus Coxsackie B4 and human Glutamic Acid Decarboxylase detecting antibodies in Latent Autoimmune Diabetes in Adults versus Type 1 Diabetes

Clinica Chimica Acta ◽

10.1016/j.cca.2021.01.002 ◽

2021 ◽

Author(s):

Feliciana Real-Fernández ◽

Alessandra Gallo ◽

Francesca Nuti ◽

Lorenzo Altamore ◽

Gloria Giovanna Del Vescovo ◽

...

Keyword(s):

Type 1 Diabetes ◽

Glutamic Acid ◽

Autoimmune Diabetes ◽

Acid Decarboxylase ◽

Peptide Epitopes ◽

Latent Autoimmune Diabetes